Aubert J F, Burnier M, Waeber B, Nussberger J, Dipette D J, Burris J F, Brunner H R
Division of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
J Pharmacol Exp Ther. 1988 Mar;244(3):1109-15.
Neuropeptide Y (NPY) is a peptide with vasoconstrictor properties known to be present in the central nervous system as well as in sympathetic nerve endings and the adrenal medulla. The purposes of this study were to investigate in normotensive conscious rats the effects of nonpressor doses of NPY on cardiac output and regional blood flow distribution (using radiolabeled microspheres) as well as on plasma renin activity, plasma catecholamine and vasopressin levels. NPY (0.1 microgram/min) infused i.v. for 30 min modified neither blood pressure nor heart rate. Cardiac index was at comparable levels in NPY- as in vehicle-treated rats (17.7 +/- 1.6, n = 8, vs. 21.3 +/- 0.9 ml/min/100 g, n = 8, mean +/- S.E.M.). There was no significant difference in regional blood flow distribution between the two groups of rats, except for the large intestine (0.42 +/- 0.06 vs. 0.71 +/- 0.1 ml/min/g in NPY- and vehicle-treated rats, respectively, P less than .05). Basal plasma renin activity and catecholamine levels were not modified by NPY whereas plasma vasopressin levels were lower (P less than .05) in rats given NPY (0.76 +/- 0.3 pg/ml, n = 8) than in those having received the vehicle (2.2 +/- 0.4 pg/ml).(ABSTRACT TRUNCATED AT 250 WORDS)
神经肽Y(NPY)是一种具有血管收缩特性的肽,已知其存在于中枢神经系统、交感神经末梢和肾上腺髓质中。本研究的目的是在正常血压的清醒大鼠中,研究非升压剂量的NPY对心输出量和局部血流分布(使用放射性标记微球)以及对血浆肾素活性、血浆儿茶酚胺和血管加压素水平的影响。静脉注射NPY(0.1微克/分钟)30分钟,血压和心率均未改变。NPY处理组大鼠的心脏指数与给予赋形剂处理组大鼠相当(分别为17.7±1.6,n = 8,与21.3±0.9毫升/分钟/100克,n = 8,平均值±标准误)。两组大鼠除大肠外,局部血流分布无显著差异(NPY处理组和赋形剂处理组大鼠分别为0.42±0.06和0.71±0.1毫升/分钟/克,P<0.05)。基础血浆肾素活性和儿茶酚胺水平不受NPY影响,而给予NPY的大鼠(0.76±0.3皮克/毫升,n = 8)的血浆血管加压素水平低于接受赋形剂的大鼠(2.2±0.4皮克/毫升)。(摘要截短于250字)